Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Breast Neoplasms × AZD9496 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Postmenopausal Women With ER+ HER2- Primary Breast Cancer 1 ER+ HER2- Advanced Breast Cancer 1 Breast Neoplasms 1

Interventions

Paclitaxel 72 Trastuzumab 70 Fulvestrant 48 Cyclophosphamide 45 Lapatinib 39 Capecitabine 39 pembrolizumab 37 Docetaxel 35 palbociclib 31 Carboplatin 28 Letrozole 25 olaparib 21 Gemcitabine 21 Doxorubicin 21 Everolimus 18 Taxes 17 pertuzumab 16 abemaciclib 16 Magnetic Resonance Spectroscopy 16 Bevacizumab 16 Ado-Trastuzumab Emtansine 16 exemestane 15 Vinorelbine 15 Radiotherapy 15 Cisplatin 15 130-nm albumin-bound paclitaxel 15 ribociclib 14 Albumin-Bound Paclitaxel 14 Nivolumab 13 Filgrastim 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02780713 2021-08-25

PK

AstraZeneca

Phase 1 Completed

14 enrolled 19 charts

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡